Martín, Iván Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. [electronic resource] - Annals of hematology Mar 2020 - 527-537 p. digital Publication Type: Clinical Trial; Journal Article ISSN: 1432-0584 Standard No.: 10.1007/s00277-020-03932-8 doi Subjects--Topical Terms: AgedAged, 80 and overAzacitidine--administration & dosageChromosome DeletionChromosomes, Human, Pair 7--geneticsCyclin-Dependent Kinase Inhibitor p15--geneticsDNA Methylation--drug effectsDNA, Neoplasm--geneticsDisease-Free SurvivalFemaleGTPase-Activating Proteins--geneticsHumansLeukemia, Myeloid, Acute--drug therapyMaleMiddle AgedMyelodysplastic Syndromes--drug therapyNucleophosminPromoter Regions, GeneticSurvival RateTumor Suppressor Proteins--genetics